Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SERTRALINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228786 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Actual shortage | 2024-05-24 | 2024-05-24 | 228792 |
| APO-RIVAROXABAN | 15MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228801 |
| APO-HYDRALAZINE | 25MG | TABLET TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228804 |
| APO-CLOPIDOGREL | 300MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-24 | 228813 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-04-12 | 2024-05-30 | 225101 |
| APO-ANASTROZOLE | 1MG | TABLET | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229161 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229164 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Anticipated shortage | 2024-05-30 | 2024-05-30 | 229167 |
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Actual shortage | 2024-02-16 | 2024-05-30 | 219843 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-05-30 | 227082 |
| APO-CEFEPIME | 2G | POWDER FOR SOLUTION | Actual shortage | 2024-05-24 | 2024-05-30 | 228807 |
| APO-TERBINAFINE | 250MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-30 | 227065 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Actual shortage | 2024-05-24 | 2024-05-30 | 228816 |
| APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-07-13 | 2024-05-31 | 198539 |
| APO-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-26 | 2024-05-31 | 217481 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-05-10 | 2024-05-31 | 227717 |
| APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224977 |
| APO-SITAGLIPTIN MALATE | 50MG | TABLET | Resolved | 2024-04-12 | 2024-05-31 | 224996 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |